Literature DB >> 20826796

eNOS-beta-actin interaction contributes to increased peroxynitrite formation during hyperoxia in pulmonary artery endothelial cells and mouse lungs.

Dmitry Kondrikov1, Shawn Elms, David Fulton, Yunchao Su.   

Abstract

Oxygen toxicity is the most severe side effect of oxygen therapy in neonates and adults. Pulmonary damage of oxygen toxicity is related to the overproduction of reactive oxygen species (ROS). In the present study, we investigated the effect of hyperoxia on the production of peroxynitrite in pulmonary artery endothelial cells (PAEC) and mouse lungs. Incubation of PAEC under hyperoxia (95% O(2)) for 24 h resulted in an increase in peroxynitrite formation. Uric acid, a peroxynitrite scavenger, prevented hyperoxia-induced increase in peroxynitrite. The increase in peroxynitrite formation is accompanied by increases in nitric oxide (NO) release and endothelial NO synthase (eNOS) activity. We have previously reported that association of eNOS with β-actin increases eNOS activity and NO production in lung endothelial cells. To study whether eNOS-β-actin association contributes to increased peroxynitrite production, eNOS-β-actin interaction were inhibited by reducing β-actin availability or by using a synthetic peptide (P326TAT) containing a sequence corresponding to the actin binding site on eNOS. We found that disruption of eNOS-β-actin interaction prevented hyperoxia-induced increases in eNOS-β-actin association, eNOS activity, NO and peroxynitrite production, and protein tyrosine nitration. Hyperoxia failed to induce the increases in eNOS activity, NO and peroxynitrite formation in COS-7 cells transfected with plasmids containing eNOS mutant cDNA in which amino acids leucine and tryptophan were replaced with alanine in the actin binding site on eNOS. Exposure of mice to hyperoxia resulted in significant increases in eNOS-β-actin association, eNOS activity, and protein tyrosine nitration in the lungs. Our data indicate that increased association of eNOS with β-actin in PAEC contributes to hyperoxia-induced increase in the production of peroxynitrite which may cause nitrosative stress in pulmonary vasculature.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20826796      PMCID: PMC2975172          DOI: 10.1074/jbc.M110.140269

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  32 in total

1.  Growth and density-dependent regulation of NO synthase by the actin cytoskeleton in pulmonary artery endothelial cells.

Authors:  Dmitry Kondrikov; Hye-Rim Han; Edward R Block; Yunchao Su
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2005-08-19       Impact factor: 5.464

2.  Differences in eNOS activity because of subcellular localization are dictated by phosphorylation state rather than the local calcium environment.

Authors:  Jarrod E Church; David Fulton
Journal:  J Biol Chem       Date:  2005-10-28       Impact factor: 5.157

3.  Hyperoxia-induced reactive oxygen species formation in pulmonary capillary endothelial cells in situ.

Authors:  Corinna Brueckl; Stephanie Kaestle; Alexander Kerem; Helmut Habazettl; Fritz Krombach; Hermann Kuppe; Wolfgang M Kuebler
Journal:  Am J Respir Cell Mol Biol       Date:  2005-12-15       Impact factor: 6.914

4.  Relative contributions of endothelial, inducible, and neuronal NOS to tone in the murine pulmonary circulation.

Authors:  K A Fagan; R C Tyler; K Sato; B W Fouty; K G Morris; P L Huang; I F McMurtry; D M Rodman
Journal:  Am J Physiol       Date:  1999-09

5.  Beta-actin association with endothelial nitric-oxide synthase modulates nitric oxide and superoxide generation from the enzyme.

Authors:  Dmitry Kondrikov; Fabio V Fonseca; Shawn Elms; David Fulton; Steven M Black; Edward R Block; Yunchao Su
Journal:  J Biol Chem       Date:  2009-11-28       Impact factor: 5.157

6.  The role of nitric oxide and metalloproteinases in the pathogenesis of hyperoxia-induced lung injury in newborn rats.

Authors:  A Radomski; G Sawicki; D M Olson; M W Radomski
Journal:  Br J Pharmacol       Date:  1998-12       Impact factor: 8.739

7.  Effect of cigarette smoke extract on nitric oxide synthase in pulmonary artery endothelial cells.

Authors:  Y Su; W Han; C Giraldo; Y De Li; E R Block
Journal:  Am J Respir Cell Mol Biol       Date:  1998-11       Impact factor: 6.914

8.  Regulation of hyperoxia-induced NADPH oxidase activation in human lung endothelial cells by the actin cytoskeleton and cortactin.

Authors:  Peter V Usatyuk; Lewis H Romer; Donghong He; Narasimham L Parinandi; Michael E Kleinberg; Steve Zhan; Jeffrey R Jacobson; Steven M Dudek; Srikanth Pendyala; Joe G N Garcia; Viswanathan Natarajan
Journal:  J Biol Chem       Date:  2007-06-11       Impact factor: 5.157

9.  Peroxynitrite generation and tyrosine nitration in defense responses in tobacco BY-2 cells.

Authors:  Syuhei Saito; Ayako Yamamoto-Katou; Hirofumi Yoshioka; Noriyuki Doke; Kazuhito Kawakita
Journal:  Plant Cell Physiol       Date:  2006-03-23       Impact factor: 4.927

10.  Involvement of Akt and endothelial nitric oxide synthase in ventilation-induced neutrophil infiltration: a prospective, controlled animal experiment.

Authors:  Li-Fu Li; Shuen-Kuei Liao; Cheng-Huei Lee; Chung-Chi Huang; Deborah A Quinn
Journal:  Crit Care       Date:  2007       Impact factor: 9.097

View more
  12 in total

1.  Novel peptide for attenuation of hyperoxia-induced disruption of lung endothelial barrier and pulmonary edema via modulating peroxynitrite formation.

Authors:  Dmitry Kondrikov; Christine Gross; Stephen M Black; Yunchao Su
Journal:  J Biol Chem       Date:  2014-10-14       Impact factor: 5.157

Review 2.  Endothelial nitric oxide synthase in the microcirculation.

Authors:  Xiaohong Shu; T C Stevenson Keller; Daniela Begandt; Joshua T Butcher; Lauren Biwer; Alexander S Keller; Linda Columbus; Brant E Isakson
Journal:  Cell Mol Life Sci       Date:  2015-08-25       Impact factor: 9.261

Review 3.  Redox proteomics in selected neurodegenerative disorders: from its infancy to future applications.

Authors:  D Allan Butterfield; Marzia Perluigi; Tanea Reed; Tasneem Muharib; Christopher P Hughes; Renã A S Robinson; Rukhsana Sultana
Journal:  Antioxid Redox Signal       Date:  2012-01-18       Impact factor: 8.401

4.  Flaxseed Mitigates Acute Oxidative Lung Damage in a Mouse Model of Repeated Radiation and Hyperoxia Exposure Associated with Space Exploration.

Authors:  Ralph A Pietrofesa; Charalambos C Solomides; Melpo Christofidou-Solomidou
Journal:  J Pulm Respir Med       Date:  2014

5.  Collagen IV contributes to nitric oxide-induced angiogenesis of lung endothelial cells.

Authors:  Huafang Wang; Yunchao Su
Journal:  Am J Physiol Cell Physiol       Date:  2011-02-09       Impact factor: 4.249

6.  Hyperoxia increases the elastic modulus of alveolar epithelial cells through Rho kinase.

Authors:  Kristina R Wilhelm; Esra Roan; Manik C Ghosh; Kaushik Parthasarathi; Christopher M Waters
Journal:  FEBS J       Date:  2013-12-24       Impact factor: 5.542

7.  The role of RhoA and cytoskeleton in myofibroblast transformation in hyperoxic lung fibrosis.

Authors:  Jixiang Ni; Zheng Dong; Weihong Han; Dmitry Kondrikov; Yunchao Su
Journal:  Free Radic Biol Med       Date:  2013-03-18       Impact factor: 7.376

Review 8.  Regulation of endothelial nitric oxide synthase activity by protein-protein interaction.

Authors:  Yunchao Su
Journal:  Curr Pharm Des       Date:  2014       Impact factor: 3.116

9.  Heat Shock Protein 70 Prevents Hyperoxia-Induced Disruption of Lung Endothelial Barrier via Caspase-Dependent and AIF-Dependent Pathways.

Authors:  Dmitry Kondrikov; David Fulton; Zheng Dong; Yunchao Su
Journal:  PLoS One       Date:  2015-06-11       Impact factor: 3.240

10.  Neonatal exposure to hyperoxia leads to persistent disturbances in pulmonary histone signatures associated with NOS3 and STAT3 in a mouse model.

Authors:  Andreas C Jenke; Jan Postberg; Cho-Ming Chao; Rhea van den Bruck; Samantha Lork; Janica Merkle; Laura Krampen; Patrick P Weil; Malik Aydin; Saverio Bellusci
Journal:  Clin Epigenetics       Date:  2018-03-20       Impact factor: 6.551

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.